Company Market News

Takeda Pharmaceutical Co. Ltd. (NYSE: TAK)
9:00 PM UTC, 12/12/25
Last: $14.33 Change: -0.06 %Change: -0.42% Volume: 2,123,444
Takeda Canada Says Health Canada Granted Market Authorization for Fruzaqla

Back

Last updated: 01/21/2025 4:40:09 AM

04:40 AM EST, 01/21/2025 (MT Newswires) -- Takeda Pharmaceutical's (TAK) Takeda Canada said Monday that Health Canada has provided market authorization for Fruzaqla for the treatment of certain adult patients with metastatic colorectal cancer.

The authorization is based on data from two phase 3 trials in which Fruzaqla plus best supportive care showed "significant improvements in overall survival," with corresponding improvements in progression free survival, compared with placebo, the company said.

http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.




Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.